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Introduction
The chromosomal passenger complex (CPC), which consists of 
the kinase Aurora B and the regulatory subunits INCENP, Sur-
vivin, and Borealin/Dasra, plays a key role in controlling chro-
mosome segregation and cytokinesis. The CPC was named for 
its subcellular distribution in mitosis; it localizes on chromo-
some arms in prophase and, during prometaphase, accumulates 
at inner centromeres. At the onset of anaphase, the CPC leaves 
centromeres and transfers to the central spindle. Aurora B phos-
phorylates multiple substrates, including histone H3 at serine-10 
(H3S10ph) on chromatin, mitotic centromere-associated kinesin 
(MCAK) at inner centromeres, centromere protein A Serine-7,   
phosphorylated (CENP-AS7ph) at outer centromeres, and KNL1/
Mis12 complex/Ndc80 complex (KMN) network proteins at   
kinetochores (Ruchaud et al., 2007; Welburn et al., 2010).
Aurora B has attracted particular attention because of 
its functions in regulating kinetochore–microtubule (KT-MT) 
attachments and spindle checkpoint signaling. If a chromosome 
attaches to microtubules such that tension is not generated 
across sister kinetochores, Aurora B acts to destabilize the 
erroneous attachment. In current models, centromeric Aurora B 
phosphorylates KMN network proteins at kinetochores, reducing 
their binding to microtubules (Cheeseman et al., 2006; DeLuca 
et al., 2006; Liu et al., 2009; Welburn et al., 2010). In this way, 
Aurora B produces unattached kinetochores that prevent satis-
faction of the mitotic spindle checkpoint until all chromosomes 
establish  tension-generating  (typically  bi-oriented)  microtubule 
attachments (Biggins and Murray, 2001; Tanaka et al., 2002; 
Hauf et al., 2003; Pinsky et al., 2006; Yang et al., 2009). Emerg-
ing evidence suggests that Aurora B also plays a more direct 
role in spindle checkpoint signaling that is independent of its 
role in correcting KT-MT attachments (Biggins and Murray, 
H
aspin phosphorylates histone H3 at threonine-3   
(H3T3ph),  providing  a  docking  site  for  the 
Aurora  B  complex  at  centromeres.  Aurora  B 
functions to correct improper kinetochore–microtubule 
attachments  and  alert  the  spindle  checkpoint  to  the 
presence of misaligned chromosomes. We show that 
Haspin inhibitors decreased H3T3ph, resulting in loss 
of centromeric Aurora B and reduced phosphorylation 
of  centromere  and  kinetochore  Aurora  B  substrates.   
Consequently,  metaphase  chromosome  alignment  and 
spindle checkpoint signaling were compromised. These 
effects  were  phenocopied  by  microinjection  of  anti-
H3T3ph antibodies. Retargeting Aurora B to centromeres 
partially restored checkpoint signaling and Aurora B–
dependent phosphorylation at centromeres and kineto-
chores, bypassing the need for Haspin activity. Haspin 
inhibitors did not obviously affect phosphorylation of 
histone  H3  at  serine-10  (H3S10ph)  by  Aurora  B  on 
chromosome arms but, in Aurora B reactivation assays, 
recovery of H3S10ph was delayed. Haspin inhibitors 
did not block Aurora B localization to the spindle mid-
zone  in  anaphase  or  Aurora  B  function  in  cytokine-
sis. Thus, Haspin inhibitors reveal centromeric roles of   
Aurora B in chromosome movement and spindle check-
point signaling.
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Aurora A, Aurora B–INCENP, Aurora C, Nek2, Plk1, and Mps1   
(for further selectivity data on >270 kinases, see Cuny et al., 2010, 
2012), and 5-iodotubercidin was much less potent against or did 
not inhibit Cdk1–Cyclin B, Aurora A, Aurora B–INCENP, Nek2, 
Bub1, Plk1, or Mps1 in vitro (Balzano et al., 2011; for further 
selectivity data, see Fedorov et al., 2007; and De Antoni et al. in 
this issue). A recently published study described another inhibitor 
of Haspin (CHR-6494; Huertas et al., 2012), but the selectivity   
of this molecule was less well defined, and no analysis of its 
effects on Aurora B function was reported. Here, we make use 
of 5-iodotubercidin, LDN-192960, and LDN-211898 to deter-
mine the function of Haspin kinase activity in mitotic cells, with 
emphasis on its role in regulating Aurora B at centromeres.
Results
Three distinct compounds inhibit H3T3 
phosphorylation by Haspin in vitro and  
in cells
We determined IC50 values for inhibition of H3T3 peptide phos-
phorylation by full-length Haspin of 3 nM for 5-iodotubercidin, 
10 nM for LDN-192960, and 100 nM for LDN-211898 (Fig. S1, 
A–C). These values are consistent with previous studies (Patnaik 
et al., 2008; Cuny et al., 2010, 2012; Balzano et al., 2011), and 
demonstrate that these three molecules show a range of potencies 
for Haspin inhibition in vitro.
To  determine  compound  potency  for  Haspin  inhibition   
in cells, we arrested HeLa cells in mitosis using nocodazole, then 
added Haspin inhibitors in the continued presence of nocodazole 
(and MG132 to counter mitotic exit) for 1 h. Immunoblotting of 
cell lysates for H3T3ph showed that all three inhibitors strongly 
inhibited Haspin (Fig. 1 A), with relative potencies that reflected 
their in vitro activity. In contrast, none of the inhibitors had 
a detectable effect on the Aurora B product H3S10ph at these 
doses (but see later in this paper). Immunofluorescence analysis 
confirmed that all three inhibitors reduced H3T3ph in mitotic 
U2OS cells. Notably, although 1 µM 5-iodotubercidin or LDN-
192960, or 5 µM LDN-211898 caused dramatic reductions in 
H3T3ph, complete loss of detectable H3T3ph required >3 µM   
5-iodotubercidin,  >5  µM  LDN-192960,  or  >30  µM  LDN-
211898 (Fig. 1 B).
Haspin inhibitors delocalize the CPC from 
centromeres but not the central spindle
RNAi of Haspin causes premature loss of cohesion in mitosis 
(Dai et al., 2006). However, centromeres remained paired in   
numerous immunofluorescence experiments with all three Haspin 
inhibitors, including when spread mitotic chromosomes were 
examined (Fig. S1 D). We conclude that the inhibitors allow 
assessment of kinase-dependent functions of Haspin in the   
absence of premature sister chromatid separation, which had 
previously confounded direct analysis of the role of this kinase 
in error correction and the spindle checkpoint.
Haspin RNAi causes CPC loss from centromeres, but not   
the central spindle (Wang et al., 2010). Similarly, when added 
to nocodazole-arrested mitotic cells, all three Haspin inhibitors   
caused displacement of Aurora B from inner centromeres to a   
2001; Kallio et al., 2002; Ditchfield et al., 2003; Hauf et al., 2003; 
Petersen and Hagan, 2003; King et al., 2007; Vader et al., 2007; 
Vanoosthuyse and Hardwick, 2009; Maldonado and Kapoor, 
2011; Santaguida et al., 2011; Saurin et al., 2011; Matson et al., 
2012). However, it remains unclear whether Aurora B must 
be positioned at inner centromeres to fulfill its function in the 
spindle checkpoint, particularly because the existence of a 
kinetochore-bound population of Aurora B has been proposed 
(DeLuca et al., 2011; Petsalaki et al., 2011).
We  and  others  recently  showed  that  phosphorylation   
of histone H3 at threonine-3 (H3T3ph), by Haspin creates a 
chromatin binding site for the BIR domain of Survivin, allowing 
CPC positioning at inner centromeres in mitosis (Kelly et al., 
2010; Wang et al., 2010; Yamagishi et al., 2010). Haspin RNAi, 
or complementation of Survivin RNAi with Survivin mutants 
defective in binding to H3T3ph, reduced Aurora B accumulation 
at centromeres, diminished the Aurora B–dependent centromeric 
localization  of  MCAK,  and  weakened  the  spindle  check-
point response to the microtubule-stabilizing drug taxol (Wang   
et al., 2010; Niedzialkowska et al., 2012). However, H3S10ph, 
CENP-AS7ph, and the spindle checkpoint response to the 
microtubule-depolymerizing drug nocodazole were relatively 
unaffected. In addition, although previous work in vitro and 
using Xenopus laevis egg extracts suggested that H3T3ph con-
tributes to Aurora B activation, either by preventing an inhibitory 
effect of H3 (Rosasco-Nitcher et al., 2008) or by generating a 
high local concentration of Aurora B required to allow transac-
tivation on chromatin (Kelly et al., 2007, 2010), this effect was 
not clear after Haspin RNAi in human cells (Wang et al., 2010). 
These findings suggested two possibilities. First, some functions 
of Aurora B might be independent of Haspin and H3T3ph. For 
example, a Bub1–Sgo1 pathway that also contributes to cen-
tromeric CPC localization (Yamagishi et al., 2010; F. Wang 
et al., 2011) might be sufficient for phosphorylation of some   
Aurora B substrates, and Survivin BIR domain mutations could 
alter functions other than H3T3ph binding (Jeyaprakash et al., 
2011). Alternatively, the result could be explained if Haspin 
depletion by RNAi was incomplete in prior studies and dif-
ferent Aurora B substrates require different levels of centro-
meric Aurora B activity. Because H3T3ph is dependent on the 
kinase activity of Haspin, small molecule inhibitors of Haspin 
would provide independent means to address these questions. 
Compared with RNAi-based approaches, inhibitors offer the 
potential advantages of selective, rapid, and strong temporal 
inhibition of kinase activity without depleting the protein itself 
(Knight and Shokat, 2005), which might have kinase-independent 
functions in mitosis and roles at other cell cycle stages.
Using high-throughput chemical library screening, we 
recently identified several Haspin inhibitors (Patnaik et al., 
2008). We determined structure-activity relationships for two 
of these inhibitor classes, and selected one high-potency com-
pound from each, LDN-192960 and LDN-211898, for further 
studies (Cuny et al., 2010, 2012). A third distinct selective 
Haspin inhibitor, 5-iodotubercidin, was identified using thermal 
stability assays (Eswaran et al., 2009; Balzano et al., 2011). 
Neither LDN-192960 nor LDN-211898 significantly inhib-
ited a range of other mitotic kinases including Cdk1–Cyclin B,   253 Haspin inhibitors and centromeric Aurora B • Wang et al.
H3T3ph can maintain a significant population of the CPC at 
centromeres (Figs. 1 B and 2 A). These results provide evidence 
that the kinase activity of Haspin is required for normal cen-
tromeric localization of Aurora B, which is consistent with the 
notion that H3T3ph provides a docking site for the CPC.
Haspin inhibitors influence Aurora B 
activity toward centromeric targets
To determine functional consequences of Haspin inhibition, we 
conducted additional assays in cells previously arrested in mitosis 
diffuse distribution on chromatin, even when MG132 was in-
cluded to counter mitotic exit (Fig. 1, B and C; and Fig. 2,   
A and B). In contrast, although anaphase was disrupted at high 
doses of Haspin inhibitors (see “Live imaging of cells treated with 
Haspin inhibitors”), Aurora B was not lost from central spin-
dles (Fig. 1 D), and CPC formation was not affected (Fig. S1 E). 
Direct comparison of H3T3ph and Aurora B staining suggested 
that maximal displacement of preaccumulated centromeric CPC 
required >3 µM 5-iodotubercidin, >10 µM LDN-192960, or 
>100 µM LDN-211898, which suggested that even low levels of 
Figure 1.  Haspin inhibitors reduce H3T3ph and displace Aurora B from centromeres but not the central spindle. (A) HeLa cells were released from 
double thymidine block and, after 7 h, 5 µM nocodazole was added for 6 h. Mitotic cells collected by “shake-off” were replated in 5 µM nocodazole, 
20 µM MG132, and Haspin inhibitors for 1 h. Immunoblots of cell lysates are shown. (B) U2OS cells were released from thymidine block and, after 7 h,   
33 nM nocodazole was added. After another 4 h, 0.33 µM nocodazole, 20 µM MG132, and kinase inhibitors were added for 1 h before fixation 
and immunofluorescence microscopy. To visualize residual H3T3ph, two different red channel exposure times are shown. (C) The ratio of centromere to 
chromosome arm Aurora B intensity was determined for cells treated as in B (15 centromeres/cell; n = 8 or 9 cells). Means + SD are shown (error bars); 
***, P < 0.001 vs. DMSO. (D) Asynchronous U2OS cells were treated with Haspin inhibitors for 2 h. Immunofluorescence microscopy of anaphase 
cells is shown. Bars, 5 µm.JCB • VOLUME 199 • NUMBER 2 • 2012   254
Figure 2.  Haspin inhibitors influence the maintenance of Aurora B activity toward centromeric targets. (A) Nocodazole-arrested U2OS cells were ob-
tained as in Fig. 1 B, then kinase inhibitors and 20 µM MG132 were added for 1 h in the presence (MCAK and Aurora B) or absence (CENP-AS7ph and 
H3S10ph) of 0.33 µM nocodazole. Mitotic Aurora B localization, the centromeric staining intensity of MCAK and CENP-AS7ph, and H3S10ph intensity on 255 Haspin inhibitors and centromeric Aurora B • Wang et al.
inhibition was likely caused by delocalization of Aurora B, and 
was unlikely to be caused by direct inhibition of Aurora B.
Previously, we detected only minor changes in phosphor-
ylation of the Aurora B target CENP-AS7 after Haspin RNAi 
(Wang et al., 2010). However, all three Haspin inhibitors sub-
stantially reduced CENP-AS7ph in nocodazole-treated cells 
(Fig. 2, A and C; and Fig. S2 A), and this loss could be rescued 
by forced targeting of Aurora B to centromeres with CENP-
B–INCENP (Fig. 3 B). A comparison of MCAK and CENP-
AS7ph staining in U2OS cells showed that loss of CENP-AS7ph 
required higher inhibitor doses than loss of MCAK (Fig. 2 A), a 
finding confirmed by costaining in individual HeLa cells (Fig. S2), 
in nocodazole. This stringent test minimizes indirect effects on 
other stages of the cell cycle and assesses maintenance of mi-
totic functions rather than their establishment. Indeed, loss of 
phosphorylation in these circumstances is likely to be depen-
dent on phosphatase activity. Nevertheless, we observed loss of 
MCAK from centromeres upon Haspin inhibitor treatment in 
both U2OS (Fig. 2, A and B) and HeLa cells (Fig. S2 A). The 
loss of MCAK caused by Haspin inhibition, but not that caused 
by direct inhibition of Aurora B, could be rescued by artificially 
restoring Aurora  B  to  centromeres  using  a  CENP-B  fusion   
protein (Liu et al., 2009) containing residues 47 to 920 of INCENP 
(Fig. 3 A). This confirmed that loss of MCAK caused by Haspin 
chromosomes were classified for at least 100 cells in each condition in one experiment by immunofluorescence microscopy. Similar results were obtained 
in duplicate experiments. (B and C) Example images of cells treated as in A. Bars, 5 µm. (D) The intensities of CENP-AS7ph and H3S10ph on mitotic 
chromosomes in each condition were quantified (n = 6–14 cells). Results are expressed as a ratio to centromeric autoantigen staining intensity at the same 
centromeres. Means + SD are shown (error bars); ***, P < 0.001 vs. DMSO.
 
Figure 3.  Artificial retargeting of Aurora B restores MCAK and CENP-AS7ph at centromeres of Haspin-inhibited cells. (A and B) HeLa cells were transfected 
with CENP-B–EGFP or EGFP–CENP-B–INCENP plasmids between double thymidine treatments. 7 h after release from G1/S, 30 nM nocodazole was 
added to accumulate mitotic cells. Then, 3.5 h later, medium containing 20 µM MG132 with or without 10 µM Haspin inhibitors or 50 nM Hesperadin, in 
the presence (A) or absence (B) of 0.33 µM nocodazole, was added for 75 min. Approximately 100 mitotic cells in each condition from one experiment 
were classified according to the intensity of centromeric MCAK (A) or CENP-AS7ph (B) by immunofluorescence microscopy. Similar results were obtained 
in a second experiment. Bars, 5 µm.JCB • VOLUME 199 • NUMBER 2 • 2012   256
(Fig. 4, B and C), which suggests that, in these experimental 
circumstances, H3T3ph-dependent accumulation of the CPC 
can contribute to activation of Aurora B and phosphorylation of 
substrates on chromosome arms. Retargeting of Aurora B to 
centromeres using CENP-B–INCENP in the presence of Haspin 
inhibitors caused H3S10ph to increase first at centromeric re-
gions, but also modestly increased the rate at which H3S10ph 
returned on chromosome arms (Fig. S3, C and D), which is con-
sistent with a report that centromeric activation of Aurora B can 
enhance phosphorylation of Aurora B targets at distant sites   
(E. Wang et al., 2011).
We then determined if this kinetic difference in Aurora B 
activation was relevant in a relatively unperturbed mitosis. In cells 
entering mitosis in the presence of Haspin inhibitors, H3S10 
remained strongly phosphorylated, even in cells in which CENP-
AS7ph was greatly reduced (Fig. S3 E). Together, these findings 
indicate that activation of Aurora B for CENP-AS7 phosphory-
lation at centromeres is more strongly dependent on the correct 
Haspin-mediated localization of the CPC than H3S10ph on chro-
mosome arms, but that increased centromeric Aurora B localiza-
tion can contribute to arm substrate phosphorylation in certain 
experimental situations.
Haspin inhibitors compromise  
error correction
To determine if the Haspin-dependent population of the CPC 
is required for KT-MT error correction, we performed monas-
trol release assays. Monastrol is a kinesin-5/Eg5 inhibitor that 
prevents centrosome separation during mitotic entry, resulting 
in the formation of monopolar spindles with erroneously at-
tached chromosomes. Upon removal of monastrol, correction 
of these attachments is hindered in the presence of Aurora B 
inhibitors (Lampson et al., 2004). All three Haspin inhibitors 
compromised the efficiency of chromosome alignment in this 
assay, with the order of potency expected (Fig. S4 A). As 
described earlier, we reasoned that the relatively high com-
pound concentrations required might be caused by the presence 
of already strongly phosphorylated Aurora B substrates at the 
time of monastrol washout into Haspin inhibitors, allowing 
substantial error correction before Haspin-dependent Aurora B 
targets became dephosphorylated. We therefore conducted as-
says in which Aurora B was initially inhibited but activa-
tion  was  allowed  upon  monastrol  and  Hesperadin  washout. 
In  this  format,  all  three  Haspin  inhibitors  strongly  hindered 
chromosome alignment at all tested doses (Fig. 5 A). In these 
assays, we were unable to determine if retargeting Aurora B 
to centromeres could rescue the defect because expression of   
CENP-B–INCENP itself disrupts error correction, presumably 
because  the  increased  local  concentration  of Aurora  B  near 
kinetochores decreases microtubule binding (Liu et al., 2009; 
Becker et al., 2010). Nevertheless, the results indicate that the 
CPC population targeted by the Haspin–H3T3ph pathway is   
required for efficient error correction.
Phosphorylation  of  several  KMN  network  proteins  in-
cluding KNL1, Dsn1, and Hec1/Ndc80 at kinetochores con-
tributes to the regulation of microtubule attachment (Welburn 
et al., 2010). Consistent with a role of the Haspin-dependent 
and consistent with our previous observation that CENP-AS7ph 
is less sensitive to loss of Haspin activity than MCAK localiza-
tion (Wang et al., 2010).
To examine the effect of Haspin inhibition on Aurora B   
activity beyond centromeres, we used an antibody that recognizes 
H3S10ph on chromosome arms (Dai et al., 2005; Wang et al., 
2010). Immunofluorescence staining showed that H3S10ph was 
not detectably decreased, even at high concentrations of Haspin 
inhibitors (Fig. 2, A and C), and in cells in which CENP-AS7ph 
was reduced (Fig. 2, C and D). Aurora B inhibitors such as Hes-
peradin caused a strong reduction in H3S10ph, confirming that 
H3S10ph dephosphorylation can be efficient in these conditions 
(Fig. 2, A, C, and D). We conclude that in these experimental 
circumstances, Haspin is required for the full activity of Aurora 
B toward centromeric targets such as MCAK and CENP-A, but 
that H3S10 phosphorylation on chromosome arms is signifi-
cantly less dependent on Haspin.
A role for Haspin in Aurora B activation
Previous studies suggested that H3T3ph contributes to activa-
tion of Aurora B (see Introduction). Indeed, Aurora B activation 
at centromeres is proposed to be crucial for generating a gradi-
ent of Aurora B activity emanating from centromeres that can 
phosphorylate substrates across chromosomes (E. Wang et al.,   
2011) and along spindle microtubules (Tseng et al., 2010; Tan 
and Kapoor, 2011). This seems at odds with our finding that 
H3S10ph is insensitive to Haspin inhibition. However, the stud-
ies described so far were performed in cells first blocked in   
nocodazole, in which Aurora B is strongly active and its sub-
strates phosphorylated before inhibitor addition.
To test if Haspin influences Aurora B activation, we used 
conditions in which Aurora B is initially inhibited in mitotic 
cells, but reactivation is then allowed upon removal of Aurora B 
inhibitor (Fig. 4 A). After treatment with Hesperadin in the   
absence of Haspin inhibitors, Aurora B was partly delocalized, 
as expected (F. Wang et al., 2011), but still showed some accu-
mulation at centromeres (Fig. S3, A and B). After removal of 
Hesperadin, Aurora B resumed a strongly centromeric localiza-
tion (Fig. S3, A and B), and CENP-AS7ph at centromeres and 
H3S10ph on chromosome arms returned to near maximal levels 
within 1 h (Fig. 4, B and C). Notably, Aurora B autophosphory-
lation at Thr-232 (Aurora B-T232ph; representing an activated 
form of the kinase; Yasui et al., 2004) recovered more quickly   
at centromeres than did Aurora B localization (Fig. S3 B), which 
is consistent with rapid Aurora B activation at centromeres. 
When we repeated these experiments in the presence of Haspin 
inhibitors, Aurora B was initially diffuse on chromosomes, and 
did not recover its centromeric localization upon removal of 
Hesperadin (Fig. S3, A and B). Aurora B autophosphorylation 
recovered slowly throughout the chromatin and did not show an 
accumulation at the centromere (Fig. S3, A and B). Consistent 
with delayed activation of centromeric Aurora B, phosphoryla-
tion of CENP-AS7 was strongly reduced in these conditions 
(Fig. 4, B and C). In contrast, H3S10ph did recover strongly, 
showing that strong centromeric accumulation of Aurora B is 
not essential for H3S10ph generation on arms. However, the   
kinetics of H3S10ph recovery were delayed by Haspin inhibition 257 Haspin inhibitors and centromeric Aurora B • Wang et al.
Live imaging of cells treated with  
Haspin inhibitors
To directly observe the effects of Haspin inhibitors on mitosis, 
we performed time-lapse microscopy of U2OS cells expressing 
histone H2B-mRFP and -tubulin–GFP (Fig. 6 A and Video 1; 
Dai et al., 2009). All three inhibitors caused a moderate increase 
CPC population in error correction, Haspin inhibitors strongly   
reduced the phosphorylation of Dsn1 at the Aurora B target 
residue S109 (Dsn1-S109ph) in Aurora B reactivation assays 
(Fig. 5, B and C; and Fig. S4 B), and Dsn1 phosphorylation could 
be largely restored by retargeting Aurora B to centromeres using 
CENP-B–INCENP (Fig. 5, D and E).
Figure 4.  Haspin inhibitors delay Aurora B activation. (A) Treatment scheme for Aurora B reactivation assays. (B) Immunofluorescence microscopy of 
CENP-AS7ph and H3S10ph in HeLa cells treated as in A. Bar, 5 µm. (C) Approximately 100 mitotic cells in each condition from one experiment were 
classified according to the intensity of CENP-AS7ph or H3S10ph staining. Similar results were obtained in a second experiment using the Aurora B inhibi-
tor ZM447439.JCB • VOLUME 199 • NUMBER 2 • 2012   258
Figure 5.  Haspin inhibitors compromise KT-MT attachment correction. (A) HeLa cells were released from thymidine treatment and, after 7 h, 100 µM 
monastrol was added for 3 h to accumulate cells in mitosis with incorrect KT-MT attachments. Then 50 nM Hesperadin was added to inhibit Aurora B, 
together with 20 µM MG132. After 1.5 h, monastrol and Hesperadin were removed by washing into fresh medium containing Haspin inhibitors or controls 259 Haspin inhibitors and centromeric Aurora B • Wang et al.
was able to drive mitotic exit in these conditions (Fig. 7 A). We 
also found that a dose of the Aurora B inhibitor ZM447439 (1 µM) 
that did not itself cause detectable mitotic exit was able to lower 
by 10-fold the concentration of 5-iodotubercidin needed to 
drive exit (Fig. 7 A). Similar findings were made with a second 
Aurora B inhibitor, Hesperadin (Fig. S5 B).
To confirm that loss of MPM-2 reactivity reflected exit 
from mitosis, we repeated similar experiments but examined cells 
by fluorescence microscopy. Indeed, 5-iodotubercidin caused a 
dose-dependent increase in the fraction of cells exiting mitosis, 
as judged by chromosome decondensation and formation of in-
terphase nuclei (Fig. 7 B). Although CENP-B–INCENP does not 
precisely restore the CPC to its normal location and dynamics at 
inner centromeres, we determined if targeting Aurora B to cen-
tromeres with this fusion protein would rescue the checkpoint 
response in 5-iodotubercidin–treated cells. We observed a statis-
tically significant increase in the proportion of cells remaining in 
mitosis in 5 µM nocodazole in the presence of the Haspin inhibi-
tor (Fig. 7 B), confirming that the checkpoint defect is likely to be 
at least partially caused by delocalization of the CPC.
To corroborate the results in another cell type and to di-
rectly visualize mitotic exit, we used U2OS cells expressing his-
tone H2B-mRFP and -tubulin–GFP. Mitotic exit was monitored 
by microscopic imaging of living cells for 15 h. Cells exhibiting 
membrane ruffling and blebbing characteristic of telophase cells, 
followed by chromatin decondensation (and often cell spread-
ing), were judged to have exited mitosis. Control cells maintained 
in 5 µM nocodazole exited mitosis or died at a low and approxi-
mately constant rate over this time, as expected (Brito and Rieder, 
2009). In contrast, addition of 100 nM of the Aurora B inhibitor 
Hesperadin caused the majority of cells to exit mitosis within the 
first 3 h, even in the continued presence of 5 µM nocodazole (P < 
0.0001 by log-rank test; Fig. 7 E). 5-Iodotubercidin also caused a 
dose-dependent increase in the rate of cells exiting mitosis (P < 
0.0001 for 1 or 3 µM 5-iodotubercidin vs. DMSO; Fig. 7 F), which 
suggests that the Haspin-dependent pool of Aurora B is required 
to maintain full checkpoint activity in cells that are exposed to 
high doses of nocodazole.
We also tested the ability of the other two Haspin inhibitors 
to stimulate mitotic exit in 5 µM nocodazole. LDN-192960 alone 
did not cause detectable exit in the MPM-2 assay in HeLa cells 
(Fig. 7 C, right). However, we suspected that this might be caused 
by the occurrence of off-target effects of this compound at 
doses >5 µM. We therefore tested if the dose of LDN-192960 
needed to influence mitotic exit could be lowered by combina-
tion with Aurora B inhibitors, as for 5-iodotubercidin. Indeed, 
in the presence of 1 µM ZM447439, even concentrations as low 
as 0.1 µM LDN-192960 caused substantial loss of MPM-2 epit-
opes (Fig. 7 C, middle), and similar results were obtained in the 
in the length of mitosis, defined as the period between nuclear 
envelope breakdown (NEB) and anaphase onset (Fig. S4 C). 
This was reminiscent of a similar extension of mitosis reported 
for cells treated with Aurora B inhibitors (Girdler et al., 2006; 
Maciejowski et al., 2010; Hégarat et al., 2011). We also noted a 
dose-dependent decline in the number of cells entering mitosis. 
This effect was not apparent in prior RNAi studies, and whether 
it reflects a role for Haspin outside mitosis or off-target effects 
of the compounds requires further investigation.
All three compounds caused a dose-dependent increase   
in  the  proportion  of  defective  mitoses.  Lagging  chromo-
somes at anaphase were often observed, even at relatively low 
inhibitor concentrations (Fig. 6, B and D; and Video 2). At 
higher concentrations, cells that entered anaphase with chro-
mosomes that had not congressed, or that entered anaphase with 
ill-defined or “loose” metaphase plates, became increasingly 
apparent (Fig. 6, B–D). At 10 µM of the most potent inhibitor, 
5-iodotubercidin, cytokinesis often occurred without obvious 
chromosome disjunction. In these cases, the cytokinetic furrow 
impinged upon the chromosome mass, resulting in a “cut-like” 
phenotype (Fig. 6 C and Video 3) resembling that seen upon 
microinjection  of  antibodies  against  H3T3ph  (Wang  et  al., 
2010). Similar mitotic figures, in which central spindle forma-
tion was evident in the absence of obvious anaphase chromo-
some movements, were seen in fixed cells previously treated 
with 10 µM 5-iodotubercidin or 100 µM LDN-211898 (Fig. 1 D). 
These results support the conclusion that Haspin inhibition 
causes defects in error correction, but that it does not affect the 
central spindle functions of Aurora B or prevent cytokinesis.
Haspin inhibitors compromise maintenance 
of the spindle checkpoint
The finding that inhibitor-treated cells could exit mitosis before 
chromosomes were fully aligned suggested either that the spin-
dle checkpoint was satisfied on such spindles, or that a defect in 
the spindle checkpoint was present. Either of these could result 
from loss of Haspin-dependent CPC activity because inhibition 
of Aurora B stabilizes KT-MT attachments and can therefore 
indirectly promote satisfaction of the spindle checkpoint, and 
there is also evidence that Aurora B plays a role in the check-
point that is independent of its function in error correction (see 
Introduction). To test this second possibility, we monitored the 
effect of Haspin inhibitors on mitotic exit of HeLa cells previ-
ously arrested with high doses of nocodazole (5 µM) that are suf-
ficient to prevent assembly of spindle microtubules detectable 
by immunofluorescence (Fig. S5 A; Jordan et al., 1992; Brito 
and Rieder, 2006). 5-Iodotubercidin caused a dose-dependent 
decrease in mitotic (phospho)-protein monoclonal-2 (MPM-2) 
phosphoepitopes detected by immunoblotting, indicating that it 
in the continued presence of MG132. Approximately 200 cells were classified in each condition by fluorescence microscopy. Means ± SD are shown 
(error bars), n = 3. (B) Immunofluorescence microscopy of Dsn1-S109ph during Aurora B reactivation in the presence or absence of Haspin inhibitors in 
cells treated as in Fig. 4 A. (C) Approximately 100 mitotic cells in each condition from one experiment as in B were classified according to phosphory-
lated Dsn1 (Dsn1-S109ph) or total Dsn1 (Dsn1) staining intensity at kinetochores. Similar results were obtained in a duplicate experiment. (D) HeLa cells 
were transfected with plasmids encoding CENP-B–EGFP or EGFP–CENP-B–INCENP between and after double thymidine treatments, then treated as in B.   
(E) The intensity of Dsn1-S109ph staining in EGFP-positive cells from D was classified in one experiment as in C. Similar results were obtained in a duplicate 
experiment. Bars, 5 µm.
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in the checkpoint assays, addition of Haspin inhibitors caused a   
modest reduction in the intensity of BubR1 at kinetochores in   
a subset of cells (Fig. S5 C). However, in Aurora B reactivation   
assays (conducted with 5 µM nocodazole), the recovery of BubR1 
at kinetochores was substantially delayed in the presence of 
Haspin inhibitors (Fig. 8, A and B; and Fig. S5 D), and this   
could be rescued by expression of CENP-B–INCENP (Fig. 8,   
C and D). Therefore, the failure of delocalized Aurora B to effi-
ciently recruit BubR1 to kinetochores (either by a direct or indi-
rect mechanism) may contribute to the checkpoint deficit seen 
in Haspin-inactivated cells.
Microinjection of H3T3ph antibodies 
compromises error correction and 
maintenance of the spindle checkpoint
We previously showed that microinjection of antibodies recog-
nizing H3T3ph into mitotic cells results in displacement of the 
presence of Hesperadin (Fig. S5 B). However, 10 µM LDN-
192960 did not cause mitotic exit in combination with Aurora B 
inhibition, which is consistent with off-target effects at this 
higher dose (Fig. S5 B). In contrast, like 5-iodotubercidin, 
LDN-211898 was able to drive mitotic exit of HeLa (Fig. 7 D) 
and U2OS cells (P < 0.0001; Fig. 7 G) in the presence of 5 µM 
nocodazole, and this could be partly prevented by expression 
of CENP-B–INCENP (Fig. 7 B). Again, the effects of LDN-
211898 were stronger in the presence of low concentrations of 
ZM447439 or Hesperadin in HeLa (Fig. 7 D and Fig. S5 B) and 
U2OS cells (P < 0.0001; Fig. 7 H). Therefore, all three Haspin 
inhibitors can compromise the spindle checkpoint when micro-
tubules are severely disrupted.
Loss of the checkpoint protein BubR1 from kinetochores 
upon Aurora B inactivation has been widely reported (Ditchfield 
et al., 2003; Hauf et al., 2003; Emanuele et al., 2008; Becker   
et al., 2010). In high nocodazole conditions similar to those used   
Figure 6.  Haspin inhibitors compromise chromosome alignment. (A) U2OS cells expressing Histone-H2B-mRFP and -tubulin–GFP were exposed to vehicle 
alone (DMSO), and mitotic progression was followed by live confocal fluorescence microscopy. Maximum intensity projections of H2B-mRFP fluorescence 
from selected frames are shown. Video 1 shows complete data including -tubulin–GFP fluorescence. (B and C) As above, for a cell treated with 10 µM LDN-
211898 (B) or 10 µM 5-iodotubercidin (C). Arrowheads indicate misaligned or lagging chromosomes. Asterisks indicate the first frame in which cytokinetic 
furrowing was observed. Also see Videos 2 and 3. Bars, 10 µm. (D) Mitotic defects enumerated from live imaging movies. See Fig. S4 C for further details.261 Haspin inhibitors and centromeric Aurora B • Wang et al.
either indirect through error correction or a more direct one in 
generating the spindle checkpoint signal itself.
At  3.3  µM  nocodazole,  a  dose  that  strongly  disrupts 
microtubules in LLC-PK cells (Vandré and Borisy, 1989), 
anti-H3T3ph–injected cells exited mitosis slightly sooner than 
control cells, although this difference was not statistically sig-
nificant (P = 0.1; Fig. 9 C). As with low doses of Haspin inhibi-
tors, we reasoned that antibody injection might not be potent 
enough to reveal the role of H3T3ph-dependent CPC in the 
spindle checkpoint. Therefore, we combined anti-H3T3ph mi-
croinjection with a dose of Aurora B inhibitor that itself was 
insufficient to cause mitotic exit in 3.3 µM nocodazole. Upon 
treatment with 1 µM ZM447439, the median time to mitotic 
exit was 13 h, similar to controls in the absence of ZM447439. 
However,  coinjection  of  anti-H3T3ph  reduced  the  median   
mitotic exit time to 5 h (P < 0.0001; Fig. 9, A and D), whereas 
microinjection of control antibodies had no significant effect 
(P = 0.48; Fig. 9 E). Therefore, microinjection of anti-H3T3ph 
antibodies can compromise the spindle checkpoint even when 
microtubules are strongly disrupted.
CPC from centromeres, defects in chromosome alignment, and 
onset of cytokinesis in the presence of misaligned chromosomes 
(Wang et al., 2010), all effects that are reminiscent of Haspin inhi-
bition reported here. To test the role of H3T3ph in error correction 
and maintenance of the spindle checkpoint in a chemical inhibitor– 
independent manner, we used live imaging to determine the effect 
of anti-H3T3ph microinjection on LLC-PK cells. Consistent with 
the results of Haspin inhibition, microinjection of anti-H3T3ph 
compromised chromosome alignment during release from a   
kinesin-5/Eg5 inhibitor block (Video 4). To examine mitotic exit, 
we used LLC-PK cells expressing EGFP–topoisomerase II that 
were previously arrested in mitosis with nocodazole. These cells 
accumulated efficiently in mitosis at 0.17 µM nocodazole, and 
exited at a median time of 9 h after live imaging was initiated. In 
contrast, cells injected with anti-H3T3ph exited mitosis with a 
median time <4 h (P < 0.0001 by log-rank test; Fig. 9, A and B). 
This supports the idea that the H3T3ph-dependent CPC popula-
tion plays a role in the timing of mitotic exit. However, because 
residual microtubules remain present in LLC-PK cells in these 
conditions (Centonze and Borisy, 1991), this function could be 
Figure 7.  Haspin inhibitors compromise the spindle checkpoint response to 5 µM nocodazole. (A) HeLa cells were synchronized by thymidine treat-
ment and, 7 h after release, 5 µM nocodazole was added for 7.5 h. Mitotic cells were harvested by mitotic “shake-off” and replated in the continued 
presence of 5 µM nocodazole together with 5-iodotubercidin and the Aurora B inhibitor ZM447439. After 13.5 h, total cell lysates were analyzed by 
immunoblotting. (B) HeLa cells were transfected with EGFP–CENP-B or CENP-B–INCENP–EGFP plasmids between and after double thymidine treatments, 
and then treated essentially as in A, except that cells were replated on coverslips coated with poly-d-lysine. Mitotic indices were determined from 100 
cells in each condition by DNA staining and fluorescence microscopy (n = 3). Means + SD are shown (error bars); ***, P < 0.001; ND, not detected.   
(C and D) As for A, but using LDN-192960 (C) or LDN-211898 (D). Black lines indicate that intervening lanes have been spliced out. (E–H) U2OS cells 
expressing Histone-H2B-mRFP and -tubulin–GFP were synchronized and treated with 5 µM nocodazole essentially as described for HeLa cells in A. Mitotic 
cells were replated in imaging dishes and kinase inhibitors were added in the continued presence of 5 µM nocodazole. Each symbol represents the time 
at which a cell began to exit from mitosis or die in mitosis, as determined from live imaging series collected over 15 h.JCB • VOLUME 199 • NUMBER 2 • 2012   262
Huertas et al., 2012). Prior RNAi and microinjection studies in 
cultured cells (Wang et al., 2010; F. Wang et al., 2011), together 
with protein depletion in Xenopus extracts (Kelly et al., 2010) 
and gene deletion in fission yeast (Yamagishi et al., 2010), re-
vealed a role for Haspin in regulating chromatin localization 
of the CPC in mitosis. Using Haspin inhibitors, we now show 
Discussion
Here, we made use of small molecule inhibitors to determine 
functions of Haspin in mitosis. As expected, Haspin inhibitors 
strongly reduce phosphorylation of histone H3 at threonine-3 in 
cells (Dai et al., 2005; Patnaik et al., 2008; Balzano et al., 2011; 
Figure 8.  Haspin inhibitors delay BubR1 recruitment to kinetochores. (A) Immunofluorescence microscopy of BubR1 during Aurora B reactivation in the 
presence or absence of Haspin inhibitors in HeLa cells treated as in Fig. 4 A, but using 5 µM nocodazole throughout. Bar, 5 µm. (B) Approximately 100 
mitotic cells in each condition from A were classified according to BubR1 intensity at kinetochores. Means ± SD are shown (error bars), n = 3. (C) HeLa 
cells were transfected with plasmids encoding EGFP–CENP-B or CENP-B–INCENP–EGFP between and after double thymidine treatments, and then treated 
essentially as in A. Bars, 5 µm. (D) For cells in C, the intensity of kinetochore BubR1 was classified in at least 100 cells per condition in one experiment. 
Similar results were obtained in a duplicate experiment.263 Haspin inhibitors and centromeric Aurora B • Wang et al.
Figure 9.  Microinjection of mitotic cells with anti-H3T3ph compromises the spindle checkpoint response in combination with Aurora B inhibition. (A) LLC-PK 
expressing EGFP-topoisomerase II arrested in mitosis with 0.17 µM (left) or 3.3 µM nocodazole (right) were injected with anti-H3T3ph solution containing 
Dextran Texas red, and time-lapse phase contrast and fluorescence images were collected every 15 min. Note the nuclear reformation at the last time point 
in each case. Times are in hours:minutes. Bar, 10 µm. (B–E) After treatment with the nocodazole and ZM447439 combinations indicated, exit from mitosis 
or death in mitosis was enumerated from live imaging series collected over 15 h as in A.JCB • VOLUME 199 • NUMBER 2 • 2012   264
in cells. Thresholds of this type regulate cell cycle events at the 
cellular level (Coudreuse and Nurse, 2010), but are also likely 
to be crucial for regional regulation of substrate phosphoryla-
tion on a local scale.
Aurora B clearly influences spindle checkpoint responses, 
although  the  mechanisms  involved  have  been  debated  (see 
Introduction). We find that, like Aurora inhibitors, Haspin in-
hibitors or microinjection of H3T3ph antibodies compromise 
maintenance of mitotic arrest when microtubules are severely 
disrupted. This suggests that the H3T3ph-dependent popula-
tion of the CPC is required for this activity of Aurora B. This 
provides support for the idea that Aurora B contributes to gen-
eration of the checkpoint response separately from its role in 
modulating KT-MT attachments, and reduces the concern that 
off-target effects of Aurora inhibitors were responsible for the 
effects observed in prior studies. Although we cannot rule out 
the possibility that Haspin inhibition or anti-H3T3ph micro-
injection also affects another population of the CPC or another 
component  of  the  checkpoint  pathway  (also  see  De Antoni   
et al., 2012), we find that the effects of Haspin inhibitors can be 
partially reversed by retargeting Aurora B to centromeres with 
CENP-B–INCENP. Our results therefore suggest that the spin-
dle checkpoint involves centromeric CPC. Whether the relevant 
substrates are within “striking distance” of Aurora B bound to 
centromeres or depend on a gradient of diffusible Aurora B   
activity centered on centromeres requires further study. Because 
the CPC can act as a tension sensor, it remains possible that 
Aurora B in the checkpoint pathway responds to tension, but it 
should be noted that our results do not imply that the checkpoint 
must necessarily be directly responsive to tension.
Previous studies using Haspin RNAi failed to reveal strong 
effects on CENP-AS7ph or spindle checkpoint responses in no-
codazole (Wang et al., 2010), which suggests that Haspin was 
incompletely depleted in these studies. In contrast to Haspin in-
hibitors, Haspin RNAi causes a prolonged mitotic delay and 
premature loss of sister chromatid cohesion in a subset of cells 
(Dai et al., 2006, 2009). These results suggest that the role of 
Haspin in cohesion either (a) is independent of its kinase activ-
ity  or  (b)  becomes  apparent  only  when  Haspin  is  partially   
depleted. Indeed, although strong depletion of certain kineto-
chore proteins compromises the spindle checkpoint, partial de-
pletion of the same proteins can prevent checkpoint satisfaction 
(McCleland et al., 2003; Meraldi et al., 2004; Meraldi and 
Sorger, 2005), a condition that might promote “cohesion fa-
tigue” (Daum et al., 2011; Stevens et al., 2011; Logarinho et al., 
2012). Further work is required, but we cannot rule out explana-
tion (a) because Haspin overexpression increases arm cohesion 
(Dai et al., 2006), kinase-deficient mutants of Haspin support 
cohesion (unpublished data), and we did not observe cohesion 
loss at intermediate inhibitor concentrations that might mimic 
partial Haspin depletion.
As with any inhibitor study, we cannot entirely rule out 
off-target effects of Haspin inhibitors, particularly when high 
concentrations are used. However, there is a strong theoretical 
basis for the need to robustly inhibit enzyme activity in cells to 
cause clear effects, particularly for indirect targets such as the 
substrates of Aurora B examined here (Knight and Shokat, 2005). 
that it is the kinase activity of Haspin that is important for the 
normal positioning of Aurora B on mitotic chromatin, and that 
this effect is independent of changes in chromosome cohesion. 
This finding is consistent with the proposed function of H3T3ph 
to provide a binding site for Survivin on chromatin (Kelly et al., 
2010; Wang et al., 2010; Yamagishi et al., 2010; Niedzialkowska 
et al., 2012).
Although H3T3ph is the only currently known product of 
Haspin activity, it is possible that other substrates of Haspin ex-
ist in cells. Nevertheless, Haspin inhibitors are useful tools to 
displace H3T3ph-dependent centromeric CPC to examine its 
functions in mitosis without preventing CPC localization to the 
central spindle, particularly in combination with artificial retar-
geting of Aurora B to centromeres. Another study used actino-
mycin D to delocalize centromeric CPC, but this also compromised 
midbody localization, and the displacement mechanism and its 
specificity remain undefined (Becker et al., 2010). Using Haspin 
inhibitors, we confirmed that the Haspin-dependent CPC pool 
is required for maintaining centromeric MCAK localization 
(Wang et al., 2010). In addition, we reveal that centromeric 
(CENP-AS7) and kinetochore (Dsn1 S109) Aurora B substrates, 
and its function in error correction, depend on this predomi-
nantly centromeric population. This lends support to models 
that emphasize the role of inner centromeric CPC in controlling 
the phosphorylation of kinetochore substrates and microtubule 
attachment stability (Tanaka et al., 2002; Liu et al., 2009).
We also find that Haspin-dependent CPC accumulation 
increases the rate of Aurora B activation, particularly for centro-
mere and kinetochore substrates. This supports, in cells, sug-
gestions made previously from work in Xenopus extracts and 
in vitro (Rosasco-Nitcher et al., 2008; Kelly et al., 2010). It is 
likely that swift concentration and activation is important for 
feedback regulation of centromeric Aurora B activity on short 
timescales, such as in response to KT-MT attachment status 
(Salimian et al., 2011). In contrast, although H3T3ph-depen-
dent localization of Aurora B can increase the rate of H3S10 
phosphorylation, this predominantly centromeric Aurora B 
population may not be strictly necessary for generating H3S10ph 
on chromosome arms. In fact, when Haspin is inhibited in 
Aurora B reactivation assays, Aurora B autophosphorylation 
and H3S10ph return in a diffuse manner that is not first focused 
at centromeres. This suggests that not all CPC functions require 
centromeric concentration for activation, nor a soluble gradient 
of Aurora B activity originating at centromeres. If this were the 
case, we might expect H3S10ph on arms, at the base of such a 
gradient, to be particularly sensitive to loss of centromeric CPC, 
but this is not the case. This suggests that, when largely diffuse 
on chromatin, the CPC can still reach a concentration sufficient 
to activate Aurora B for H3S10 phosphorylation. Presumably, 
the population of Aurora B found prominently on chromosome 
arms in prophase cells (Ruchaud et al., 2007) contributes di-
rectly to H3S10 phosphorylation. It is likely that different target 
sites phosphorylated by Aurora B have different susceptibilities 
to Aurora B and opposing phosphatases (Xu et al., 2009; Wang 
et al., 2010) due both to site-intrinsic features, such as binding 
affinity, and extrinsic factors, such as substrate abundance. H3S10 
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encoding EGFP-CENP-B[1–167] in pEGFP-C1 (Wordeman et al., 2007) 
was  provided  by  L.  Wordeman,  and  transfections  were  done  with   
Fugene 6 (Roche).
Immunofluorescence microscopy
In general, cells grown on coverslips were fixed for 10 min with 2% para-
formaldehyde in PBS and extracted with 0.5% Triton X-100 in PBS for   
5 min, at room temperature. For the error correction assay shown in Figs. 5 A   
and S4 A, cells were fixed with 4% paraformaldehyde in PBS for 10 min 
without extraction. For experiments shown in Fig. 5 (B–E), cells were ex-
tracted for 5 min in PHEM (60 mM Pipes, 25 mM Hepes, 10 mM EGTA, 
and 2 mM MgCl2, pH 6.9) plus 1% Triton X-100, and fixed at room temper-
ature for 20 min in PHEM plus 4% formaldehyde. For experiments shown 
in Fig. S5 A, cells were fixed with 4% paraformaldehyde in PBS for 10 min 
followed by ice-cold methanol treatment for 5 min. Mitotic chromosome 
spreads were prepared in hypotonic buffer (75 mM KCl/0.8% sodium 
citrate/H2O at 1:1:1), attached to glass slides by Cytospin (Thermo Fisher 
Scientific) at 1,500 rpm for 5 min, fixed with 2% paraformaldehyde in   
PBS for 20 min at room temperature, and stained with antibodies in 10% 
FBS, 0.1% Triton X-100, 120 mM KCl, 20 mM, MgCl2, 0.5 mM EDTA, 
and 10 mM Tris, pH 8.0 (Dai et al., 2006). Blocking was performed 
in 5% milk in 0.1% or 0.5% Triton X-100 in PBS, and antibodies were 
diluted in blocking buffer and incubated at room temperature for 1–2 h or 
overnight at 4°C. DNA was visualized with 1 µM Hoechst 33342 (Thermo 
Fisher Scientific). Fluorescence microscopy was performed at room tem-
perature using a 60× Plan-Apochromat (NA 1.40) oil immersion objec-
tive lens and an inverted microscope (TE2000-U; Nikon) equipped with a 
SPOT-RT charge-coupled device system and SPOT-RT software (Diagnostic 
Instruments, Inc.). Photoshop (Adobe) was used to adjust maximum and 
minimum image brightness using “levels” (equally for all images in a single 
experiment) and assemble image panels.
Live imaging of U2OS cells
U2OS cells stably expressing -tubulin–EGFP (human -tubulin fused to the 
N terminus of EGFP in plasmid pEGFP-N1) and H2B-mRFP (human histone 
H2B fused to the N terminus of mRFP in plasmid pmRFP-N1) were used 
(Dai et al., 2009). For imaging, mitotic cells arrested in 5 µM nocodazole 
for 8 h were harvested by “shake-off” and replated in 10% FBS, 25 mM 
Hepes, and phenol red–free DME (Thermo Fisher Scientific) containing 5 µM   
nocodazole in a 35-mm single chamber (World Precision Instruments) or 
35-mm 4-chamber (Greiner Bio-One) glass-bottom dishes coated with poly-
d-lysine. Time-lapse confocal fluorescence imaging was performed using 
an inverted microscope (TE2000-U; Nikon) equipped with a 40× Plan 
Fluor (NA 1.30) oil immersion objective lens, a confocal laser scanner (C1 
Plus; Nikon), EZ-C1 software (Nikon), and a Proscan II motorized stage 
(Prior Scientific) in a 37°C heated chamber with CO2 supply. Immediately 
after kinase inhibitor addition, two-color z stacks with 0.8 µm steps were 
collected with a 100-nm pinhole every 5 min for 15 h. ImageJ (National 
Institutes of Health) was used to render maximum intensity projections, 
adjust brightness, and assemble movies.
Live imaging and microinjection of LLC-PK cells
For assays as in Video 4, asynchronous LLC-PK cells were treated with 
10 µM 5-S-trityl-l-cysteine and 25 µM MG132 for 1 h. After mounting in 
imaging chambers, monopolar mitotic cells were injected using a Burleigh 
micromanipulator, and microneedles containing 4.5 mg/ml affinity-purified 
rabbit anti-H3T3ph antibody in PBS. After 10 min, 5-S-trityl-l-cysteine 
was removed by changing to medium containing 25 µM MG132 without 
5-S-trityl-l-cysteine. For assays in Fig. 9, a stable LLC-PK cell line express-
ing human topoisomerase II fused to the C terminus of EGFP (in plasmid 
pEGFP-C3) was used (Tavormina et al., 2002). Cells were injected with   
14 mg/ml anti-H3T3ph or rabbit IgG in PBS containing 0.5 mg/ml dextran 
Texas red. During imaging, 10% FBS in Leibovitz’s L-15 medium supple-
mented with penicillin and streptomycin and overlaid with mineral oil was 
used. Time-lapse phase contrast and fluorescence images were collected 
at 37°C using a 63× objective lens (NA 1.40) and an inverted micros-
cope (Axiovert 200M; Carl Zeiss, Inc.) equipped with a stage heater, air 
curtain, an ORCA-ER camera (Hamamatsu Photonics), and MetaMorph 
software (Molecular Devices), or using a 63× (NA 1.40) oil objective and 
an inverted microscope (AxioObserver; Carl Zeiss, Inc.) equipped with a 
stage heater, air curtain, an ORCA-ER camera, and Slidebook software 
(Intelligent Imaging Innovations, Inc.). Images were captured every 2 min 
(Video 4) or 15 min (Fig. 9). Individual cells were evaluated after a minimum 
observation period of 3 h (Video 4) or 15 h (Fig. 9). Image panels were 
assembled using MetaMorph software.
Indeed, recent studies highlight the importance of using high 
Aurora inhibitor concentrations to reveal Aurora B check-
point functions (Santaguida et al., 2011). Furthermore, we dem-
onstrate that three chemically distinct compounds yield similar 
phenotypes in cells at relative doses predicted by their ability to 
inhibit Haspin in vitro and in cells. It seems unlikely that all 
three inhibitors have a fortuitous off-target activity that would 
track Haspin inhibition capacity so closely. Furthermore, we 
used combination treatments with Haspin and Aurora B inhibi-
tors to demonstrate effects at low doses that are less likely to 
display off-target effects, and we confirmed a role for H3T3ph 
in error correction and the spindle checkpoint using H3T3ph 
antibody microinjection experiments that eliminate the use of 
Haspin inhibitors.
The  difficulty  in  fully  inhibiting  Aurora  B  activity  in 
cells by targeting Haspin or Aurora B directly may stem in part 
from a positive feedback loop between these kinases that drives   
Aurora B localization in mitosis (F. Wang et al., 2011). Indeed, 
it is possible that coinhibition of Haspin and Aurora B will pro-
vide means to enhance the effects of Aurora B inhibitors cur-
rently in clinical trials (Lens et al., 2010), and a compound that 
inhibits Haspin has shown anti-tumor activity in a mouse xeno-
graft model (Huertas et al., 2012). It seems more certain that the 
Haspin inhibitors we describe will be useful for further basic 
studies of chromosome segregation.
Materials and methods
Antibodies
Rabbit polyclonal antibodies used were to H3T3ph (B8634 raised against 
Histone H3(1–8)T3ph peptide; Dai et al., 2005), -tubulin (AK-15; Sigma-
Aldrich), Dsn1 no. 110 and Dsn1-S109ph no. 20 (provided by I. Cheeseman,   
Whitehead Institute, Cambridge, MA; Welburn et al., 2010), Aurora B 
T232ph  (Rockland  Immunochemicals),  CENP-AS7ph  (EMD  Millipore), 
INCENP (I5283; Sigma-Aldrich), and Survivin (NB500-201; Novus Bio-
logicals). Mouse monoclonal antibodies used were to H3S10ph (6G3; 
Cell  Signaling  Technology),  mitotic  phospho-epitopes  (MPM-2;  EMD   
Millipore), Aurora B (AIM-1; BD), and -Tubulin (B-5-1-2; Sigma-Aldrich). 
Sheep antibodies were to Aurora B and BubR1 (SAB.1 and SBR1.1; S. Taylor, 
University of Manchester, Manchester, UK; Ditchfield et al., 2003) and 
MCAK (L. Wordeman, University of Washington, Seattle, WA; Andrews 
et al., 2004), and human centromere autoantibodies (abbreviated “cen-
tromere” in figures) were from ImmunoVision. Secondary antibodies were 
donkey anti–rabbit or –mouse IgG-HRP; anti–rabbit, –mouse, or –sheep IgG-
Cy3; anti–human, –mouse, –sheep, or –rabbit IgG-Cy5 (Jackson Immuno-
Research Laboratories, Inc.); or anti–rabbit, –sheep, or –mouse IgG–Alexa   
Fluor 488 (Invitrogen).
Cell culture and inhibitors
HeLa and U2OS cells were maintained in 10% FBS/DME at 10% CO2 
and 37°C. Cells were arrested at the G1/S boundary by single or double 
2 mM thymidine (EMD) treatment, or in prometaphase with nocodazole 
(Sigma-Aldrich) at stated concentrations. MG132 (Sigma-Aldrich) was 
used at 20 µM. LDN-211898 (Cuny et al., 2012) was synthesized by 
Aberjona Laboratories, LDN-192960 was provided by M. Robin (Cen-
tre Saint Jérôme, Aix-Marseille Université, Marseille, France; Cuny et al., 
2010),  and  5-iodotubercidin  was  from  EMD  Millipore.  ZM447439   
(Ditchfield et al., 2003) was obtained from Tocris Bioscience, and Hespera-
din (Hauf et al., 2003) was obtained from Selleck Chemicals. For monastrol 
release experiments (Lampson et al., 2004), cells were treated with 100 µM   
monastrol (Sigma-Aldrich) for 2 h, followed by washing four times and 
incubation in medium containing 20 µM MG132. A plasmid encoding 
a fusion protein of the CENP-B DNA binding domain, CENP-B[1–158] 
to human INCENP[47–920] and EGFP in pEGFP-N1 (Liu et al., 2009) 
was provided by M. Lampson (University of Pennsylvania, Philadelphia,   
PA) and S. Lens (University Medical Center, Utrecht, Netherlands), a plasmid JCB • VOLUME 199 • NUMBER 2 • 2012   266
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Quantification of immunofluorescence
Quantification of immunofluorescence in fixed mitotic cells was performed 
using ImageJ using images obtained at identical illumination settings. The 
total pixel intensity of CENP-AS7ph, H3S10ph, and centromere autoanti-
gen staining within ellipses encompassing individual cells was determined, 
and the average background pixel intensity was obtained from a smaller 
ellipse within the cell cytosol. After background subtraction, the ratio of 
total histone phosphorylation/centromere autoantigen intensity was calcu-
lated for each cell. MCAK, CENP-AS7ph, Dsn1, Dsn1-S109ph, and BubR1 
intensity levels were quantified at 18 centromeres per cell as follows. Cen-
tromeres were defined as regions falling within a 10-pixel diameter circle 
encompassing paired centromere autoantigen dots. The average pixel 
intensity within these circles was determined for centromere autoantigen 
and test staining. After background correction, the ratio of test/centromere 
autoantigen intensity was calculated for each centromere (Wang et al., 
2010). Ratios were normalized to a mean value of 1 in controls.
The ratio of Aurora B at centromeres versus chromosome arms was 
determined as follows. The intensity of Aurora B and centromere autoanti-
gen staining was determined within 10 × 4 pixel ellipses encompassing 
paired centromere dots. After background correction, the ratio of Aurora B 
to centromere autoantigen intensity was calculated independently for each 
of 15 centromeres per cell. After background subtraction, the average 
intensity of Aurora B within 10 × 4 pixel ellipses at three locations on chro-
mosome arms was normalized to the mean centromere autoantigen intensity 
in the same cell. The mean centromere/arm intensity ratio was then cal-
culated for each cell (Niedzialkowska et al., 2012).
Statistical analysis
Statistical analyses of immunofluorescence data were performed by one-
way analysis of variance (ANOVA) followed by a Bonferroni’s multiple 
comparison test, using Instat 2.03 (GraphPad Software). Kaplan-Meier 
curves and log-rank tests on mitotic exit were performed using Prism 4 
(GraphPad Software). The results shown were calculated using datasets 
from which cells dying in mitosis were excluded, but similar results were 
obtained if these cells were included.
Immunoprecipitation and immunoblotting
Whole cell lysates for Fig. 1 A were prepared in standard 1× SDS sample 
buffer with protease inhibitors and phosphatase inhibitors as described 
previously (Wang et al., 2010). For Fig. S1 E, cells were lysed in buffer P 
and subjected to immunoprecipitation with 3 µg/ml normal sheep IgG 
(EMD Millipore) or sheep anti–Aurora B antibody followed by immunoblot-
ting as described previously (Wang et al., 2010).
In vitro kinase reactions
Time-resolved  fluorescence  resonance  energy  transfer  (TR-FRET)  assays 
were  performed  using  recombinant  full-length  human  MBP-Haspin  at  a 
near-Km concentration of ATP (200 µM) with 0.1 µM biotinylated H3(1–21) 
peptide substrate for 10 min at room temperature. Phosphorylation was 
detected by TR-FRET after addition of Europium-labeled anti-H3T3ph anti-
body clone JY325 (EMD Millipore) and streptavidin-APC (PerkinElmer) in a 
final concentration of 25 mM EDTA (Patnaik et al., 2008).
Online supplemental material
Fig.  S1  shows  Haspin  inhibitor  structures  and  IC50s,  and  that  they  do 
not cause cohesion loss or disassemble the CPC. Fig. S2 shows effects 
of Haspin inhibitors on centromeric MCAK and CENP-AS7ph. Fig. S3 
shows effects on H3S10ph and Aurora B localization and autophosphor-
ylation in Aurora B reactivation assays. Fig. S4 shows effects on error 
correction and the duration of mitosis. Fig. S5 shows disruption of micro-
tubules by nocodazole, the effects of Haspin and Aurora B coinhibition 
using Hesperadin, and effects of Haspin inhibition on BubR1 localization.   
Videos 1–3 show the effects of Haspin inhibitors on mitosis by live imaging. 
Video 4 shows the effects of anti-H3T3ph microinjection on error correc-
tion. Online supplemental material is available at http://www.jcb.org/cgi/ 
content/full/jcb.201205106/DC1.
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